Skip to main content Accessibility help
×
Home

The seroepidemiology of Bordetella pertussis infection in Western Europe

  • R. G. PEBODY (a1), N. J. GAY (a1), A. GIAMMANCO (a2), S. BARON (a3), J. SCHELLEKENS (a4), A. TISCHER (a5), R.-M. ÖLANDER (a6), N. J. ANDREWS (a1), W. J. EDMUNDS (a1), H. LECOEUR (a7), D. LÉVY-BRUHL (a3), P. A. C. MAPLE (a8), H. DE MELKER (a4), A. NARDONE (a1), M. C. ROTA (a9), S. SALMASO (a9), M. A. E. CONYN-VAN SPAENDONCK (a4), S. SWIDSINSKI (a10) and E. MILLER (a1)...

Abstract

High titres of pertussis toxin (PT) antibody have been shown to be predictive of recent infection with Bordetella pertussis. The seroprevalence of standardized anti-PT antibody was determined in six Western European countries between 1994 and 1998 and related to historical surveillance and vaccine programme data. Standardized anti-PT titres were calculated for a series of whole-cell and acellular pertussis vaccine trials. For the serological surveys, high-titre sera (>125 units/ml) were distributed throughout all age groups in both high- (>90%) and low-coverage (<90%) countries. High-titre sera were more likely in infants in countries using high-titre-producing vaccines in their primary programme (Italy, 11·5%; Western Germany, 13·3%; France, 4·3%; Eastern Germany, 4·0%) compared to other countries (The Netherlands, 0·5%; Finland, 0%). Recent infection was significantly more likely in adolescents (10–19 years old) and adults in high-coverage countries (Finland, The Netherlands, France, East Germany), whereas infection was more likely in children (3–9 years old) than adolescents in low-coverage (<90%; Italy, West Germany, United Kingdom) countries. The impact and role of programmatic changes introduced after these surveys aimed at protecting infants from severe disease by accelerating the primary schedule or vaccinating older children and adolescents with booster doses can be evaluated with this approach.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The seroepidemiology of Bordetella pertussis infection in Western Europe
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The seroepidemiology of Bordetella pertussis infection in Western Europe
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The seroepidemiology of Bordetella pertussis infection in Western Europe
      Available formats
      ×

Copyright

Corresponding author

Dr R. G. Pebody, Immunisation Department, Communicable Disease Surveillance Centre, Health Protection Agency, 61 Colindale Avenue, London, UK. (Email: Richard.Pebody@hpa.org.uk)

The seroepidemiology of Bordetella pertussis infection in Western Europe

  • R. G. PEBODY (a1), N. J. GAY (a1), A. GIAMMANCO (a2), S. BARON (a3), J. SCHELLEKENS (a4), A. TISCHER (a5), R.-M. ÖLANDER (a6), N. J. ANDREWS (a1), W. J. EDMUNDS (a1), H. LECOEUR (a7), D. LÉVY-BRUHL (a3), P. A. C. MAPLE (a8), H. DE MELKER (a4), A. NARDONE (a1), M. C. ROTA (a9), S. SALMASO (a9), M. A. E. CONYN-VAN SPAENDONCK (a4), S. SWIDSINSKI (a10) and E. MILLER (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed